AKT1 and cancer: In the mechanism study of Komura and Zhang et al., it was found that TAMs can upregulate the expression of PD-L1 in cancer cells by activating the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signaling pathway [17, 18].